Skip to main content

CORRECTION article

Front. Pharmacol., 08 September 2023
Sec. Pharmacology of Anti-Cancer Drugs
This article is part of the Research Topic Different Cell Death Modes in Cancer Treatment View all 9 articles

Corrigendum: Paraptosis: a unique cell death mode for targeting cancer

Sweata Hanson&#x;Sweata Hanson1Aiswarya Dharan&#x;Aiswarya Dharan1Jinsha P. V.Jinsha P. V.1Sanjay PalSanjay Pal1Bipin G. NairBipin G. Nair1Rekha KarRekha Kar2Nandita Mishra
Nandita Mishra1*
  • 1School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam, Kerala, India
  • 2Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX, United States

A Corrigendum on
Paraptosis: a unique cell death mode for targeting cancer

by Hanson S, Dharan A, P. V. J, Pal S, Nair BG, Kar R and Mishra N (2023). Front. Pharmacol. 14:1159409. doi: 10.3389/fphar.2023.1159409

In the published article, there was an error in Table 3 as published. The cell line type and the signalling pathway and mechanism attributed to the article by Garrido-Armas et al. (2018) was incorrect. The corrected Table 3 appear below.

TABLE 3
www.frontiersin.org

TABLE 3. Paraptosis-inducing compounds against cancer cell lines.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cancer, paraptosis, programmed cell death, alternative cell death, cancer therapy, apoptosis

Citation: Hanson S, Dharan A, V. JP, Pal S, Nair BG, Kar R and Mishra N (2023) Corrigendum: Paraptosis: a unique cell death mode for targeting cancer. Front. Pharmacol. 14:1274076. doi: 10.3389/fphar.2023.1274076

Received: 07 August 2023; Accepted: 25 August 2023;
Published: 08 September 2023.

Edited and reviewed by:

Zhaoshi Bai, The Affiliated Cancer Hospital of Nanjing Medical University, China

Copyright © 2023 Hanson, Dharan, V., Pal, Nair, Kar and Mishra. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Nandita Mishra, bmFuZGl0YW1pc2hyYUBhbS5hbXJpdGEuZWR1

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.